|
ESCO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16090004276259E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75070000052457E-07 |
| Normal-vs-Stage2 |
5.21789999985423E-07 |
| Normal-vs-Stage3 |
4.2893000040678E-08 |
| Normal-vs-Stage4 |
1.87869997336776E-09 |
| Stage1-vs-Stage2 |
1.680990E-01 |
| Stage1-vs-Stage3 |
1.458160E-01 |
| Stage1-vs-Stage4 |
8.604900E-03 |
| Stage2-vs-Stage3 |
7.957400E-01 |
| Stage2-vs-Stage4 |
4.782000E-01 |
| Stage3-vs-Stage4 |
2.571600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76800002310773E-09 |
| Normal-vs-AfricanAmerican |
6.421800E-03 |
| Normal-vs-Asian |
2.9331999999993E-06 |
| Caucasian-vs-AfricanAmerican |
3.857800E-01 |
| Caucasian-vs-Asian |
9.352200E-01 |
| AfricanAmerican-vs-Asian |
4.043800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91939999952362E-08 |
| Normal-vs-Female |
5.19179998992314E-09 |
| Male-vs-Female |
8.189200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.06579999997947E-06 |
| Normal-vs-Age(41-60Yrs) |
1.09150000149327E-08 |
| Normal-vs-Age(61-80Yrs) |
1.2845999819433E-09 |
| Normal-vs-Age(81-100Yrs) |
1.138870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.393380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.450300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.357400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.061400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.706600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.155200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.302200E-02 |
| Classical-VS-Follicular |
1.878250E-02 |
| Classical-VS-Other |
6.627400E-01 |
| Classical-VS-Normal |
2.88910000034726E-07 |
| Tall-VS-Follicular |
9.162000E-01 |
| Tall-VS-Other |
6.515200E-01 |
| Tall-VS-Normal |
4.00040000014812E-07 |
| Follicular-VS-Other |
7.480200E-01 |
| Follicular-VS-Normal |
6.30030000392523E-08 |
| Other-VS-Normal |
2.722200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.69790001239789E-09 |
| Normal-vs-N1 |
8.00489999952525E-07 |
| N0-vs-N1 |
5.627600E-01 |
|
|
